We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

34 hedge funds and large institutions have $4M invested in Achieve Life Sciences in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more capital invested

Capital invested by funds: $3.04M → $4M (+$962K)

11% less funds holding

Funds holding: 38 → 34 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

Holders
34
Holders Change
-4
Holders Change %
-10.53%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
10
Closed
8
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$51K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$64.7K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$35.5K
3
VKH
Virtu KCG Holdings
New York
+$16.7K
4
UBS Group
UBS Group
Switzerland
+$6.26K
5
AIM
Acrospire Investment Management
Illinois
+$4.18K

Top Sellers

1
PAM
Panagora Asset Management
Massachusetts
-$175K
2
BIT
BlackRock Institutional Trust
California
-$73.1K
3
BFA
BlackRock Fund Advisors
California
-$62.6K
4
BC
Boxer Capital
California
-$60K
5
TC
TFS Capital
Pennsylvania
-$47K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$876K +$64.7K +31 +8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$841K – – –
BIT
3
BlackRock Institutional Trust
California
$776K -$73.1K -35 -9%
A
4
Abingworth
United Kingdom
$400K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$151K +$35.5K +17 +33%
EGA
6
Eagle Global Advisors
Texas
$146K – – –
PAM
7
Panagora Asset Management
Massachusetts
$134K -$175K -84 -58%
BA
8
BlackRock Advisors
Delaware
$121K -$33.4K -16 -23%
ARTA
9
A.R.T. Advisors
New York
$57K -$10.4K -5 -16%
Northern Trust
10
Northern Trust
Illinois
$55K – – –
AA
11
Ancora Advisors
Ohio
$51K -$23K -11 -32%
PI
12
Putnam Investments
Massachusetts
$50K – – –
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$49K – – –
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$46K – – –
Bank of New York Mellon
15
Bank of New York Mellon
New York
$43K – – –
HighTower Advisors
16
HighTower Advisors
Illinois
$27K -$2.09K -1 -8%
Goldman Sachs
17
Goldman Sachs
New York
$24K -$4.18K -2 -15%
Creative Planning
18
Creative Planning
Kansas
$20K – – –
VKH
19
Virtu KCG Holdings
New York
$17K +$16.7K +8 New
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$13K – – –
GC
21
Guggenheim Capital
Illinois
$12K – – –
CG
22
Cutler Group
California
$11K -$6.26K -3 -38%
Citigroup
23
Citigroup
New York
$11K – – –
State Street
24
State Street
Massachusetts
$11K – – –
TH
25
Timber Hill
Connecticut
$11K – – –
1
2

ACHV Hedge Fund Activity: Q2 2016 in Review

34 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2016, worth a combined $4M — up 32% from $3.04M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ACHV and 4 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $64.7K. The largest seller was Panagora Asset Management, cutting an estimated $175K.

  • 34 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2016, down from 38 in Q1 2016.
  • Funds reported $4M of Achieve Life Sciences stock for Q2 2016, up 32% quarter-over-quarter.
  • 4 funds opened new Achieve Life Sciences positions in Q2 2016 and 8 closed out, a net change of -4 holders.
  • The largest Achieve Life Sciences buyer in Q2 2016 was Renaissance Technologies, an estimated $64.7K added.
  • The largest Achieve Life Sciences seller in Q2 2016 was Panagora Asset Management, an estimated $175K sold.

Based on aggregated 13F filings for Q2 2016.